|
|
|
|
|
|
|
ȸ»ç¼Ò°³
Driven by the powerful R&D capability with a force of over 300 international scientists and an global extensive network, Venturepharm has over 400 non-patent infringed products approved, pending or under development and 6 NCEs before clinical stages as well as over 200 APIs and key intermediates. Venturepharm has established 8 R&D centers, 3 GMP integrated manufacture facilities and 4 bulk API manufacturing facilities, two of them are approved & USFDA inspected.
|
|
|
|
|
ÇöÈÇо÷ü°¡ Á¦Á¶ÇÏ´Â ÈÇÐÁ¦Ç° ¸ñ·Ï |
|
|
ÇöÈÇо÷ü°¡ Á¦Á¶ ¶Ç´Â ÆǸÅÇÏ´Â ÈÇй°Áú ¸ñ·Ï |
|
ÇöÈÇо÷ü·Î µî·ÏµÈ ÈÇй°ÁúÀÌ ¾ø½À´Ï´Ù! |
|
|